Search clinical trials for: Pulmicort (budesonide) Turbuhaler

Total 580 results

Hat Yai Medical Education Center

Completed

Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

Asthma

Thailand
Orion Corporation, Orion Pharma

Completed

Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
AstraZeneca

Completed

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

Asthma

France
The First Affiliated Hospital of Guangzhou Medical...
Merck Sharp & Dohme LLC

Unknown

Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma

Asthma

China
AstraZeneca

Completed

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

Asthma

Japan
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (REFLI)

Asthma

Germany
AstraZeneca

Completed

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy (RELEASE)

Asthma

United Kingdom
Cosmetique Active International

Completed

CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS

Atopic Dermatitis

Brazil
Columbia University

Withdrawn

The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton

Osteoporosis
AstraZeneca

Completed

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Asthma

Germany
Consorzio Futuro in Ricerca

Completed

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD (PMC-101-APT)

Asthma | COPD

Italy
AstraZeneca

Completed

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

Asthma

Netherlands
AstraZeneca

Completed

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
Vectura Limited

Completed

A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma

Wheezing | Reactive Airway Disease | Mild Asthma

United States
AstraZeneca

Completed

Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) (SECURE 1)

Chronic Obstructive Pulmonary Disease (COPD)

Korea, Republic of, China, Hong Kong, Thailand, Indonesia
Pearl Therapeutics, Inc.

Completed

Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®

COPD

Japan
Daping Hospital and the Research Institute of Surgery...

Completed

Curosurf/Budesonide for Infants With Respiratory Distress Syndrome (Budesonide)

Respiratory Distress Syndrome

China
Boston Children's Hospital
Brigham and Women's Hospital

Terminated

Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma

Exercise Induced Asthma

United States
AstraZeneca

Completed

MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults

Asthma

Denmark, Finland, Norway
AstraZeneca

Completed

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

Asthma

Croatia, Czech Republic, Latvia, Lithuania, Portugal, Slovakia, Greece, Iceland, Slovenia, Chile
AstraZeneca

Completed

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

Stable Asthma
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

Asthma

Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, United Kingdom
Orion Corporation, Orion Pharma

Completed

Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics (KINECO)

Asthma

United Kingdom
The University of Texas Health Science Center,...
National Center for Advancing Translational Sciences (NCATS)

Terminated

Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

United States
Mayo Clinic

No longer available

Stiripentol in Dravet Syndrome

Dravet Syndrome

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR); AllerGen NCE Inc.

Recruiting

Diesel Exhaust Induces Glucocorticoid Resistance (DIGR)

Exposure to Pollution | Glucocorticoid Resistance

Canada
GlaxoSmithKline

Completed

A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United Kingdom, Netherlands
Zhujiang Hospital

Unknown

Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)

Quality of Life | Pulmonary Disease, Chronic Obstructive | Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome | Small Airway Disease

China
Zhujiang Hospital

Unknown

Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Quality of Life | Pulmonary Disease, Chronic Obstructive | Exercise | Lung Function Decreased

China
University of Alberta
GlaxoSmithKline

Terminated

Asthma/Steroid Withdrawal Study

Asthma

Canada
King Saud University
King Fahad Medical City

Completed

The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room

Status Asthmaticus

Saudi Arabia
East Carolina University

Unknown

Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.

Bronchopulmonary Dysplasia

United States
AstraZeneca

Completed

Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children

Asthma
AstraZeneca

Completed

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease (RISE)

COPD Patients

United States, Spain, Bulgaria, Mexico, Poland, South Africa, Germany, Argentina, Chile, Czechia, Puerto Rico
GlaxoSmithKline

Completed

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Asthma

United Kingdom, Germany
National Cancer Institute (NCI)

Completed

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

Lung Cancer

Italy
Pearl Therapeutics, Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos) (KRONOS)

COPD

United States, Canada, China, Japan
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU (OCEAN)

Chronic Obstructive Pulmonary Disease

Bulgaria, Russian Federation, Romania, Ukraine, Japan
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis (RINEX50)

Rhinitis, Allergic, Perennial

Brazil
AstraZeneca

Completed

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide® (SPEED)

Chronic Obstructive Pulmonary Disease (COPD)

Brazil, United Kingdom, Germany, Philippines, Denmark, Australia, Argentina, India, Belgium
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Chronic Obstructive Pulmonary Disease, COPD

Sweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
AstraZeneca

Completed

A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)

Relative Bioavailability

United States
Hospital Central "Dr. Ignacio Morones Prieto"
Universidad Autonoma de San Luis Potosí

Unknown

Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.

Respiratory Distress Syndrome | Bronchopulmonary Dysplasia | Infant,Premature

Mexico
AAADRS Clinical Research Center
AstraZeneca

Completed

Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children

Asthma

United States
AstraZeneca

Completed

Assess Safety, Tolerability and PK of AZD3199 in Japanese

Healthy

United Kingdom
Pearl Therapeutics, Inc.

Completed

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD (telos)

Chronic Obstructive Pulmonary Disorder

United States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
AstraZeneca

Completed

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma (SYGMA2)

Asthma

Germany, Spain, Thailand, Vietnam, Bulgaria, Russian Federation, Korea, Republic of, Brazil, Hungary, Peru, Philippines, New Zealand, Poland, Saudi Arabia, South Africa, Ukraine, Romania, Czechia, Slovakia, Colombia, Mexico, Sweden, Chil... and more
GlaxoSmithKline

Completed

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Asthma

Argentina
University of Arizona

Recruiting

Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease (STOPCLD)

Acute Lung Injury | Chronic Lung Disease of Prematurity | Infant, Extremely Premature | Budesonide

United States
St. Paul's Hospital, Canada

Withdrawn

Efficacy of Budesonide Via Delayed Release vs Immediate Release

Chronic Rhinosinusitis (Diagnosis)

3

Subscribe